| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +44.6 K | 34.6% | $3.72 | +$166 K |
| Sells | 5 | -84.3 K | 65.4% | $3.76 | -$317 K |
| Net | -4 | -39.7 K | -30.8% | -$151 K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Redmile Group, LLC | Director, 10%+ Owner | $79.1 M | +$166 K | +0.21% | Jun 7, 2024 |
| J. Scott Wolchko | President and CEO, Director | $2.99 M | -$62.9 K | -2.06% | Feb 1, 2024 |
| Edward J. Dulac III | Chief Financial Officer | $1.95 M | -$96.7 K | -4.73% | Mar 4, 2024 |
| Bahram Valamehr | Chief R&D Officer | $1.92 M | -$49.4 K | -2.51% | Feb 1, 2024 |
| Cindy Tahl | General Counsel and Secretary | $1.78 M | -$106 K | -5.61% | Feb 1, 2024 |
| Yu-Waye Chu | Chief Medical Officer | $1.78 M | Apr 18, 2023 | ||
| Brian Powl | Chief Commercial Officer | $1.34 M | Jul 5, 2023 | ||
| Mark Plavsic | Chief Technical Officer | $685 K | Jan 10, 2023 | ||
| Robert Hershberg | Director | $156 K | Jun 6, 2023 | ||
| Yuan Xu | Director | $150 K | -$2.35 K | -1.54% | Jun 7, 2024 |
| Timothy Coughlin | Director | $109 K | Jun 7, 2024 | ||
| John Mendlein | Director | $109 K | Jun 7, 2024 | ||
| Karin Jooss | Director | $109 K | Jun 7, 2024 | ||
| Michael Lee | Director | $109 K | Jun 7, 2024 | ||
| Shefali Agarwal | Director | $109 K | Jun 7, 2024 | ||
| William H. Rastetter | Director | $109 K | Jun 7, 2024 | ||
| Robert S. Epstein | Director | $109 K | Jun 7, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|